130 related articles for article (PubMed ID: 34953917)
1. Deciphering metformin action in obese mice: A critical re-evaluation of established protocols.
Kaplanian M; Philippe C; Eid SA; Hackl MT; Metz M; Beghini M; Luca AC; Kautzky-Willer A; Scherer T; Fürnsinn C
Metabolism; 2022 Mar; 128():154956. PubMed ID: 34953917
[TBL] [Abstract][Full Text] [Related]
2. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice.
Shin NR; Lee JC; Lee HY; Kim MS; Whon TW; Lee MS; Bae JW
Gut; 2014 May; 63(5):727-35. PubMed ID: 23804561
[TBL] [Abstract][Full Text] [Related]
3. The importance of the AMPK gamma 1 subunit in metformin suppression of liver glucose production.
An H; Wang Y; Qin C; Li M; Maheshwari A; He L
Sci Rep; 2020 Jun; 10(1):10482. PubMed ID: 32591547
[TBL] [Abstract][Full Text] [Related]
4. Treatment with a novel agent combining docosahexaenoate and metformin increases protectin DX and IL-6 production in skeletal muscle and reduces insulin resistance in obese diabetic db/db mice.
Mitchell PL; Nachbar R; Lachance D; St-Pierre P; Trottier J; Barbier O; Marette A
Diabetes Obes Metab; 2017 Mar; 19(3):313-319. PubMed ID: 27800648
[TBL] [Abstract][Full Text] [Related]
5. Deficiency in apolipoprotein A-I ablates the pharmacological effects of metformin on plasma glucose homeostasis and hepatic lipid deposition.
Karavia EA; Hatziri A; Kalogeropoulou C; Papachristou NI; Xepapadaki E; Constantinou C; Natsos A; Petropoulou PI; Sasson S; Papachristou DJ; Kypreos KE
Eur J Pharmacol; 2015 Nov; 766():76-85. PubMed ID: 26420354
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic-pharmacodynamic analysis of the glucose-lowering effect of metformin in diabetic rats reveals first-pass pharmacodynamic effect.
Stepensky D; Friedman M; Raz I; Hoffman A
Drug Metab Dispos; 2002 Aug; 30(8):861-8. PubMed ID: 12124302
[TBL] [Abstract][Full Text] [Related]
7. Hypoglycemic and lipid lowering effects of theaflavins in high-fat diet-induced obese mice.
Cai X; Liu Z; Dong X; Wang Y; Zhu L; Li M; Xu Y
Food Funct; 2021 Oct; 12(20):9922-9931. PubMed ID: 34492673
[TBL] [Abstract][Full Text] [Related]
8. The evidence of metabolic-improving effect of metformin in Ay/a mice with genetically-induced melanocortin obesity and the contribution of hypothalamic mechanisms to this effect.
Derkach K; Zakharova I; Zorina I; Bakhtyukov A; Romanova I; Bayunova L; Shpakov A
PLoS One; 2019; 14(3):e0213779. PubMed ID: 30870482
[TBL] [Abstract][Full Text] [Related]
9. Current biochemical studies of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis suggest a new therapeutic approach.
Hookman P; Barkin JS
Am J Gastroenterol; 2003 Sep; 98(9):2093-7. PubMed ID: 14499793
[TBL] [Abstract][Full Text] [Related]
10. Metformin reduces body weight gain and improves glucose intolerance in high-fat diet-fed C57BL/6J mice.
Matsui Y; Hirasawa Y; Sugiura T; Toyoshi T; Kyuki K; Ito M
Biol Pharm Bull; 2010; 33(6):963-70. PubMed ID: 20522960
[TBL] [Abstract][Full Text] [Related]
11. No effect of metformin on the innate airway hyperresponsiveness and increased responses to ozone observed in obese mice.
Shore SA; Williams ES; Zhu M
J Appl Physiol (1985); 2008 Oct; 105(4):1127-33. PubMed ID: 18703763
[TBL] [Abstract][Full Text] [Related]
12. Acute increase in food intake after intraperitoneal injection of metformin in rats.
del Prete E; Lutz TA; Scharrer E
Physiol Behav; 1999 Nov; 67(5):685-9. PubMed ID: 10604838
[TBL] [Abstract][Full Text] [Related]
13. Glucose homeostasis in rainbow trout fed a high-carbohydrate diet: metformin and insulin interact in a tissue-dependent manner.
Polakof S; Moon TW; Aguirre P; Skiba-Cassy S; Panserat S
Am J Physiol Regul Integr Comp Physiol; 2011 Jan; 300(1):R166-74. PubMed ID: 21068202
[TBL] [Abstract][Full Text] [Related]
14. Metformin Reduces Lipogenesis Markers in Obese Mice Fed a Low-Carbohydrate and High-Fat Diet.
de Oliveira Santana KN; Lelis DF; Mendes KL; Lula JF; Paraíso AF; Andrade JM; Feltenberger JD; Cota J; da Costa DV; de Paula AM; Guimarães AL; Santos SH
Lipids; 2016 Dec; 51(12):1375-1384. PubMed ID: 27804063
[TBL] [Abstract][Full Text] [Related]
15. Metformin acutely lowers blood glucose levels by inhibition of intestinal glucose transport.
Horakova O; Kroupova P; Bardova K; Buresova J; Janovska P; Kopecky J; Rossmeisl M
Sci Rep; 2019 Apr; 9(1):6156. PubMed ID: 30992489
[TBL] [Abstract][Full Text] [Related]
16. Global gene expression analysis in liver of obese diabetic db/db mice treated with metformin.
Heishi M; Ichihara J; Teramoto R; Itakura Y; Hayashi K; Ishikawa H; Gomi H; Sakai J; Kanaoka M; Taiji M; Kimura T
Diabetologia; 2006 Jul; 49(7):1647-55. PubMed ID: 16752183
[TBL] [Abstract][Full Text] [Related]
17. Effect of metformin on the urinary metabolites of diet-induced-obese mice studied by ultra performance liquid chromatography coupled to time-of-flight mass spectrometry (UPLC-TOF/MS).
Zhu Y; Feng Y; Shen L; Xu D; Wang B; Ruan K; Cong W
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Apr; 925():110-6. PubMed ID: 23523884
[TBL] [Abstract][Full Text] [Related]
18. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
Freemark M; Bursey D
Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
[TBL] [Abstract][Full Text] [Related]
19. Involvement of glucagon-like peptide-1 in the glucose-lowering effect of metformin.
Bahne E; Hansen M; Brønden A; Sonne DP; Vilsbøll T; Knop FK
Diabetes Obes Metab; 2016 Oct; 18(10):955-61. PubMed ID: 27265206
[TBL] [Abstract][Full Text] [Related]
20. Metformin adapts its cellular effects to bioenergetic status in a model of metabolic dysfunction.
Auger C; Sivayoganathan T; Abdullahi A; Parousis A; Pang BW; Jeschke MG
Sci Rep; 2018 Apr; 8(1):5646. PubMed ID: 29618839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
